Susceptibility of Lung Carcinoma Cells to Nanostructured Lipid Carrier of ARV-825, a BRD4 Degrading Proteolysis Targeting Chimera

Aerosolized nanoliposomal carrier of remdesivir: an effective alternative for COVID-19 treatment in vitro

(2021) Richa Vartak et al.   Nanomedicine

Lung Cancer 2020

(2020) Brett C. Bade et al.   CLINICS IN CHEST MEDICINE

Axicabtagene ciloleucel CD19 CAR-T cell therapy results in high rates of systemic and neurologic remissions in ten patients with refractory large B cell lymphoma including two with HIV and viral hepatitis

(2020) Ahmed Abbasi et al.   Journal of Hematology & Oncology

An annual review of the remarkable advances in lung cancer clinical research in 2019

(2020) Bo Cheng et al.   Journal of Thoracic Disease

Targeting KRAS Mutant Non-Small-Cell Lung Cancer: Past, Present and Future

(2020) Iris Z. Uras et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Nanoformulation of PROteolysis TArgeting Chimera targeting ‘undruggable’ c-Myc for the treatment of pancreatic cancer

(2020) Aishwarya Saraswat et al.   Nanomedicine

Update on the Biology, Management, and Treatment of Small Cell Lung Cancer (SCLC)

(2020) Andreas Saltos et al.   Frontiers in Oncology

Modulating the function of ABCB1: in vitro and in vivo characterization of sitravatinib, a tyrosine kinase inhibitor

(2020) Yuqi Yang et al.   Cancer Communications

Nanostructured Lipid Carriers Delivering Sorafenib to Enhance Immunotherapy Induced by Doxorubicin for Effective Esophagus Cancer Therapy

(2020) Jia-Yang Wang et al.   ACS Omega

First-in-human study assessing safety, tolerability, and pharmacokinetics of 2-hydroxybenzylamine acetate, a selective dicarbonyl electrophile scavenger, in healthy volunteers

(2019) Lisa M. Pitchford et al.   BMC Pharmacology & Toxicology

Penetration and Uptake of Nanoparticles in 3D Tumor Spheroids

(2019) Aleksandra Tchoryk et al.   BIOCONJUGATE CHEMISTRY

BRD4 PROTAC as a novel therapeutic approach for the treatment of vemurafenib resistant melanoma: Preformulation studies, formulation development and in vitro evaluation

(2019) Drishti Rathod et al.   EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

Nanostructured lipid carriers for site-specific drug delivery

(2018) Archana Khosa et al.   BIOMEDICINE & PHARMACOTHERAPY

Targeting BRD4 proteins suppresses the growth of NSCLC through downregulation of eIF4E expression

(2018) Zhongyuan Gao et al.   CANCER BIOLOGY & THERAPY

Applications of nanoparticle systems in drug delivery technology

(2018) Syed A.A. Rizvi et al.   SAUDI PHARMACEUTICAL JOURNAL

Development of nanostructured lipid carriers for intraoral delivery of Domperidone

(2017) Carolin Tetyczka et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Nanostructured lipid carriers employing polyphenols as promising anticancer agents: Quality by design (QbD) approach

(2017) Ketki Bhise et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Novel BET protein proteolysis-targeting chimera exerts superior lethal activity than bromodomain inhibitor (BETi) against post-myeloproliferative neoplasm secondary (s) AML cells

(2017) D T Saenz et al.   LEUKEMIA

BET Proteins as Targets for Anticancer Treatment

(2017) Anastasios Stathis et al.   Cancer Discovery

Drugging the undruggables: exploring the ubiquitin system for drug development

(2016) Xiaodong Huang et al.   CELL RESEARCH

Development and Evaluation of Lipid Nanoparticles for Drug Delivery: Study of Toxicity In Vitro and In Vivo

(2016) Evelyn Winter et al.   JOURNAL OF NANOSCIENCE AND NANOTECHNOLOGY

PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer

(2016) Kanak Raina et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4

(2015) Michael Zengerle et al.   ACS Chemical Biology

Optimizing lung cancer treatment approaches

(2014) Rafael Rosell et al.   Nature Reviews Clinical Oncology

An in-tumor genetic screen reveals that the BET bromodomain protein, BRD4, is a potential therapeutic target in ovarian carcinoma

(2014) Maria Giuseppina Baratta et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Small peptide-modified nanostructured lipid carriers distribution and targeting to EGFR-overexpressing tumorin vivo

(2013) Cuiyan Han et al.   Artificial Cells Nanomedicine and Biotechnology

Gold nanoparticles as carriers for a syntheticStreptococcus pneumoniaetype 14 conjugate vaccine

(2012) Dodi Safari et al.   Nanomedicine

Duloxetine HCl Lipid Nanoparticles: Preparation, Characterization, and Dosage Form Design

(2011) Ketan Patel et al.   AAPS PHARMSCITECH

BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc

(2011) Jake E. Delmore et al.   CELL

Nanostructured lipid carriers for parenteral delivery of silybin: Biodistribution and pharmacokinetic studies

(2010) Lejiao Jia et al.   COLLOIDS AND SURFACES B-BIOINTERFACES